Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. Treatment of high-fat diet–fed.

Slides:



Advertisements
Similar presentations
Philip J. Barter, et al. Circulation 2011;124:
Advertisements

The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Fig. 1. Body growth and leptin responsivity in young CPO and CTR mice
Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity  Sara Gry Vienberg, André Kleinridders, Ryo.
Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice by Banumathi K. Cole,
In vivo selectivity of compound 6b.
The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.
Volume 138, Issue 7, Pages e1 (June 2010)
Body weight and oral glucose tolerance in diet-induced obese rats at 5 weeks post-surgery. Body weight and oral glucose tolerance in diet-induced obese.
Volume 16, Issue 7, Pages (August 2016)
Improvement of insulin sensitivity by treatment of the annexin A1 receptor agonist in HFD mice. Improvement of insulin sensitivity by treatment of the.
Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose tolerance Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose.
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
The preventive role of TR in HFD‐treated mice
a b c d OGTT OGTT *** ** * * Blood glucose (mg/dL) AUC (mg/dL/min) ND
Fig. 2. CD treatment facilitates regression of murine atherosclerosis.
Cellularity of epididymal adipose tissue.
Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:
Effect of insulin on hepcidin expression in HepG2 cells.
Glucose, insulin, and AGE levels during an OGC before and after RT
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
GSIS. GSIS. In vivo: serum insulin levels at fasting state and 30 min after glucose injection (A) and the fold change in serum insulin after glucose loading.
Ion channels expression and insulin secretion in the pancreatic islets of male offspring. Ion channels expression and insulin secretion in the pancreatic.
Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Data.
GLUT4 LXRE is required for downregulation of adipose GLUT4 mRNA during fasting and diet-induced obesity. GLUT4 LXRE is required for downregulation of adipose.
Correlation of myotube AdipoR1 (A) and AdipoR2 (B) mRNA expression with insulin secretion (n = 40). Correlation of myotube AdipoR1 (A) and AdipoR2 (B)
Skeletal muscle characteristics of HFD-induced obese mice.
Mean ± SEM concentration of insulin in plasma and CSF and glucose in plasma 30 min after the intraperitoneal administration of DET or NPH insulin at different.
Appearance of insulin in plasma and CSF at different times after the administration of subcutaneous DET and GLAR in mice and the effect of chronic DET.
Glucose tolerance in WT and TRPM2-KO mice.
Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.
A and B: Intracellular cAMP levels and lipolysis in adipocytes from chow-fed and HFD-fed mice. A and B: Intracellular cAMP levels and lipolysis in adipocytes.
Effects of the β-cell–specific expression of mKL on blood glucose levels, glucose tolerance, insulin sensitivity, and plasma insulin levels in STZ-induced.
BAFF-deficient (BAFFnull) and anti-BAFF antibody (Ab)–treated obese mice exhibit superior glucose metabolic control compared with WT and Bnull mice. BAFF-deficient.
Effects of pterosin A on serum levels of lipid, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), and alanine aminotransferase (ALT)
The effect of VSG on body weight and body fat in GLP-1r KO mice.
A: Chemical structure of pterosin A
Fig. 4 Deletion of hepatocyte HIF-2α does not affect obesity-induced glucose, glucagon, and insulin intolerance. Deletion of hepatocyte HIF-2α does not.
Treatment of ob/ob mice with TTR-ASOs reduces adipose tissue inflammation. Treatment of ob/ob mice with TTR-ASOs reduces adipose tissue inflammation. A:
Metabolic parameters of Id1−/− and wild-type mice fed a standard chow diet (hatched bars and striped bars, respectively) or a high-fat diet (black bars.
The portal-arterial (P-A) insulin gradient and arterial plasma c-peptide levels in the control period (−40 to 0 min) and after administration of the glycogen.
USP2–45 regulates hepatic gluconeogenesis.
SENP2 overexpression increases FAO by upregulating expression of FAO-associated enzymes in muscle. SENP2 overexpression increases FAO by upregulating expression.
Effect of Id1 deletion on insulin action in wild-type and Id1−/− mice fed a chow diet (white triangle/striped bar and black triangle/hatched bar, respectively)
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
Effect of cold exposure on determinants of glucose tolerance.
HFD feeding induced insulin resistance in TRIB3 MOE mice.
High-glucose–induced insulin resistance in TRIB3 MOE mice.
Hepatic fuel metabolism in male 5αR1-KO and WT mice
Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance. Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance.
Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.
Treatment of ob/ob mice with TTR-ASOs improves insulin sensitivity.
MϕRIP140KD mice exhibit improved metabolic phenotypes.
Effects of Rosi treatment on ASKO mice.
Effects of chow-diet feeding on control and TRIB3 MOE mice.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
Metabolic effects of VSG in GLP-1r KO mice.
AP2-Cre–mediated IKKβ deletion results in similar defects in adipose remodeling and accentuated inflammatory responses after HF feeding. aP2-Cre–mediated.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
Decreased M1 and increased M2 macrophages in eWAT and liver of DIO mice due to linagliptin administration. Decreased M1 and increased M2 macrophages in.
Deficiency of adipocyte IKKβ does not affect diet-induced weigh gain but results in an exaggerated diabetic phenotype when challenged with an HFD. A: IKKβ.
Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.
Effects of d-xylose or sucralose (control) with or without sitagliptin on gastric emptying (half-emptying time [T50]) (n = 12). Effects of d-xylose or.
Fig. 4 Effects of hematopoietic restoration of TLR9 on adipose tissue inflammation and insulin resistance. Effects of hematopoietic restoration of TLR9.
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Presentation transcript:

Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. Treatment of high-fat diet–fed mice with TTR-ASOs decreases circulating TTR and RBP4 levels, and improves insulin sensitivity. A: TTR mRNA in liver in male mice fed a high-fat diet after 4 weeks of ASO treatment. Plasma TTR levels in male chow-fed and high-fat diet–fed mice. *P < 0.05 vs. chow-fed mice, #P < 0.05 vs. high-fat diet–fed mice treated with saline solution or control ASO by ANOVA. B: Plasma RBP4 levels in male chow-fed and high-fat diet–fed mice after 3 weeks of ASO treatment. *P < 0.05 vs. chow-fed mice, #P < 0.05 vs. high-fat diet–fed mice treated with saline solution or control ASO by ANOVA. C: Fed insulin levels in male chow-fed and high-fat diet–fed mice prior to ASO treatment (0 weeks) and after 3.5 and 6 weeks of ASO treatment. *P < 0.05 vs. chow-fed mice, @P < 0.05 vs. high-fat diet–fed mice treated with control ASO, #P < 0.05 high-fat diet–fed mice treated with saline solution or control ASO by t test. D: Insulin tolerance test (0.4 units/kg) after 6.5 weeks of ASO treatment. *P < 0.05 for chow-fed vs. high-fat diet–fed mice treated with saline solution, control ASO, or TTR-ASO by ANOVA with repeated measures for comparison of each curve. #P < 0.05 for high-fat diet–fed mice treated with TTR-ASO vs. control ASO, P = 0.056 vs. saline solution by ANOVA with repeated measures for comparison of each curve. E: Fed LDL cholesterol levels in male chow-fed and high-fat diet–fed mice prior to ASO treatment (0 weeks) and after 6 weeks of ASO treatment. *P < 0.05 vs. chow-fed mice, #P < 0.05 vs. high-fat diet–fed mice treated with saline solution or control ASO by ANOVA. n = 4–5 per group (A); n = 6–9 per group (B–E). Data are expressed as the mean ± SEM. AU, arbitrary units; Con ASO, control ASO treatment; HFD, high-fat diet; Sal, saline solution treatment. Laura Zemany et al. Diabetes 2015;64:1603-1614 ©2015 by American Diabetes Association